Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC TAT-CBD3A6K acetate | 1505463-57-9 | 99.8% | 3249.83 (free base) | 10 MG
SDP

Catalog No. 5000425464
Encompass_Preferred

TAT-CBD3A6K acetate is a modified TAT-CBD3 peptide that reduces T- and R-type voltage-dependent calcium currents in dorsal root ganglion (DRG) neurons. It also exhibits anti-nociceptive effects in a model of AIDS-induced peripheral neuropathy by preventing CRMP-2-mediated enhancement of T- and R-type calcium channel function.

  • Reduces T- and R-type voltage-dependent calcium currents
  • Exhibits anti-nociceptive effects in AIDS-induced peripheral neuropathy models
  • Prevents CRMP-2-mediated enhancement of T- and R-type calcium channel function
  • Modified TAT-CBD3 peptide

Catalog No. 50-004-25464 Supplier Medchemexpress LLC Supplier No. HYP10358A10MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

TAT-CBD3A6K acetate is a modified TAT-CBD3 peptide that reduces T- and R-type voltage-dependent calcium currents in dorsal root ganglion (DRG) neurons. It also exhibits anti-nociceptive effects in a model of AIDS-induced peripheral neuropathy by preventing CRMP-2-mediated enhancement of T- and R-type calcium channel function.

  • Reduces T- and R-type voltage-dependent calcium currents
  • Exhibits anti-nociceptive effects in AIDS-induced peripheral neuropathy models
  • Prevents CRMP-2-mediated enhancement of T- and R-type calcium channel function
  • Modified TAT-CBD3 peptide

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.